Geistlich Pharma

[Available On-Demand]
Geistlich Pharma, a family-owned Swiss company, is a world leader in the field of biomaterials and medical devices with a successful global presence of leading brands in dentistry and orthopedics.

Geistlich Oncology, located in Princeton, NJ, is developing a product, GP-2250, a tumor-cell selective agent for cancers with high unmet need.
Company Type:
Company Website:
Company HQ State:
New Jersey
Company HQ Country:
United States
Year Founded:
1851
Main Therapeutic Focus:
Lead Product in Development:
GP-2250
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
photo
Chief Executive Officer
Geistlich Pharma North America, Inc